Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Potentiating Action of Chlorpromazine and Reserpine

Nature volume 175, pages 1133–1134 (1955)Cite this article

Abstract

THIS laboratory has previously reported that β-diethylaminoethyl diphenylpropylacetate hydrochloride (SKF 525-A) potentiates the pharmacological activity of a variety of drugs by interfering with their rate of detoxication1,2. Recently, we have become interested in the potentiating effects of chlorpromazine and reserpine, drugs widely used for their tranquillizing effects. Chlorpromazine is reported to potentiate the action of a number of central depressant drugs, including barbiturates and ethanol3. We have been able to show that reserpine as well as chlorpromazine potentiates the hypnotic action of hexobarbitone and ethanol; and furthermore, that neither potentiating agent influences the rate of metabolic transformation of the hypnotics but acts presumably by increasing the sensitivity of the central nervous system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Axelrod, J., Reichenthal, J., and Brodie, B. B., J. Pharm. and Exp. Therap., 112, 49 (1954).

    CAS  Google Scholar 

  2. Cooper, J. R., Axelrod, J., and Brodie, B. B., J. Pharm. and Exp. Therap., 112, 55 (1954).

    CAS  Google Scholar 

  3. Courvoisier, S., Fournal, J., Ducrot, R., Kolsky, M., and Koetchet, P., Arch. int. Pharmacodyn., 92, 305 (1953).

    CAS  PubMed  Google Scholar 

  4. Bucher, T., and Rodetski, M., Klin. Wochensch., 29, 615 (1951).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Chemical Pharmacology, National Heart Institute, National Institutes of Health, Bethesda, Md.

    BERNARD B. BRODIE, PARKHURST A. SHORE & STANLEY L. SILVER

  2. Geigy Company, Basle

    ROBERT PULVER

Authors
  1. BERNARD B. BRODIE
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. PARKHURST A. SHORE
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. STANLEY L. SILVER
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. ROBERT PULVER
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

BRODIE, B., SHORE, P., SILVER, S. et al. Potentiating Action of Chlorpromazine and Reserpine. Nature 175, 1133–1134 (1955). https://doi.org/10.1038/1751133a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/1751133a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing